Asian Spectator

Men's Weekly

.

The FDA approved a new drug to treat Alzheimer's, but Medicare won't always pay for it – a doctor explains what researchers know about Biogen's Aduhelm

  • Written by Andrew Williams, Assistant Professor of Emergency Medicine, Albert Einstein College of Medicine
The FDA approved a new drug to treat Alzheimer's, but Medicare won't always pay for it – a doctor explains what researchers know about Biogen's AduhelmAn illustration of amyloid plaques within the human brain, characteristic features of Alzheimer's. By 2060, approximately 14 million Americans are expected to have the disease.Kateryna Kon/Science Photo Library via Getty Images

Medicare finalized its decision to restrict its coverage of Aduhelm, Biogen’s new Alzheimer’s disease drug, on...

Magazine

Kasus Amsal Sitepu bukti birokrasi dan hukum gagal memahami sektor kreatif

(SynthEx/Shutterstock)● Penegak hukum gagal mengapresiasi nilai ekonomi ide dan proses kreatif dalam audit korupsi.● Penilaian jasa kreatif nol rupiah mengancam keberlanjutan ekonomi kreat...

Penerapan aturan deforestasi Eropa ditunda lagi: peluang membangun rantai pasok yang lebih adil

● Mengganti minyak sawit dengan alternatif lain tidak serta merta mengatasi persoalan deforestasi.● Masalah utama ada pada transparansi dan tata kelola, bukan jenis komoditasnya.● EU...

Tak ada hidup layak dalam upah minimum 2026

Claraelnisa/Shutterstock.com● UMP 2026 tak cukup untuk memenuhi kehidupan layak para pekerja.● Hal ini membuat situasi ekonomi masyarakat kian mencekam mengingat tahun ini banyak perang da...